Crystalline forms

Industry

CPC
C07B2200/13

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07BGENERAL METHODS OF ORGANIC CHEMISTRY APPARATUS THEREFOR C07B2200/00Indexing scheme relating to specific properties of organic compounds

Current Industry

C07B2200/13Crystalline forms

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
De novo design of potent and selective interleukin mimetics
- Patent number 12,227,553
- Issue date Feb 18, 2025
- University of Washington
- Daniel Adriano Silva Manzano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal forms of thiophene derivatives
- Patent number 12,227,514
- Issue date Feb 18, 2025
- Tianjin Hemay Pharmaceutical Co., Ltd.
- Donglei Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-...
- Patent number 12,227,481
- Issue date Feb 18, 2025
- Exelixis, Inc.
- Khalid Shah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polymorphisms of HM30181 mesylate
- Patent number 12,227,494
- Issue date Feb 18, 2025
- HEALTH HOPE PHARMA LIMITED
- Sameer Urgaonkar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt and crystalline form of furopyrimidine compound and pharmaceut...
- Patent number 12,227,513
- Issue date Feb 18, 2025
- TIUMBIO CO., LTD.
- Minhee Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of an NRTTI compound
- Patent number 12,227,536
- Issue date Feb 18, 2025
- Merck Sharp & Dohme LLC
- Daniel Skomski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibiting the activity of HIF2-alph...
- Patent number 12,226,405
- Issue date Feb 18, 2025
- Novartis AG
- Robin Alec Fairhurst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms and methods of producing crystalline forms of a c...
- Patent number 12,227,533
- Issue date Feb 18, 2025
- Viking Therapeutics, Inc.
- Brian Lian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystal form of acid addition salt of furopyrimidine compound
- Patent number 12,227,510
- Issue date Feb 18, 2025
- Hanmi Pharm. Co., Ltd
- Hee Sook Oh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline polymorphs of sodium (4R,12AS)-9-{[(2,4-difluorophenyl)...
- Patent number 12,227,518
- Issue date Feb 18, 2025
- MSN LABORATORIES PRIVATE LIMITED, R&D CENTER
- Thirumalai Rajan Srinivasan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms
- Patent number 12,227,532
- Issue date Feb 18, 2025
- Viatris Asia Pacific Ptd. Ltd.
- Daniel Leuenberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EGFR inhibitors
- Patent number 12,227,491
- Issue date Feb 18, 2025
- INVENTISBIO CO., LTD.
- Xing Dai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of(Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylide...
- Patent number 12,227,497
- Issue date Feb 18, 2025
- ATEGRIN, INC.
- Antonio J. Barbosa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for the preparation of 2,2′,2″-(10-((2R,3S)-1,3,4-trihydrox...
- Patent number 12,227,527
- Issue date Feb 18, 2025
- Biophore India Pharmaceuticals Pvt Ltd
- Manik Reddy Pullagurla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of diazabicyclooctane derivative and production p...
- Patent number 12,221,443
- Issue date Feb 11, 2025
- Meiji Seika Pharma Co., Ltd.
- Takao Abe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino e...
- Patent number 12,221,445
- Issue date Feb 11, 2025
- Merck Patent GmbH
- Rudolf Moser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleu...
- Patent number 12,221,446
- Issue date Feb 11, 2025
- Rudolf Moser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nε-long chain acyl lysine crystal production method and composition...
- Patent number 12,221,403
- Issue date Feb 11, 2025
- Ajinomoto Co., Inc.
- Shuvendu Biswas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of trametinib acetic acid solvate
- Patent number 12,221,440
- Issue date Feb 11, 2025
- Aurobindo Pharma Ltd.
- Gangadhara Bhima Shankar Nangi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cholinesterase inhibitor polymorph and application thereof
- Patent number 12,215,085
- Issue date Feb 4, 2025
- CHANGCHUN HUAYUAN HIGH-SCIENCE AND TECHNOLOGY CO., LTD.
- Tonghui Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal of pyrazolo[3,4-d]pyrimidine
- Patent number 12,215,109
- Issue date Feb 4, 2025
- Taiho Pharmaceutical Co., Ltd.
- Tadashi Shimamura
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{...
- Patent number 12,215,094
- Issue date Feb 4, 2025
- Celgene Corporation
- Eric A. Fromme
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid form, crystalline form, and crystal form a of FXR agonist, an...
- Patent number 12,215,098
- Issue date Feb 4, 2025
- CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
- Xiaolin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-b...
- Patent number 12,215,083
- Issue date Feb 4, 2025
- ATNX SPV, LLC
- Michael P. Smolinski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of carbazole inhibitors of RhoGTPase for the trea...
- Patent number 12,209,078
- Issue date Jan 28, 2025
- MBQ Pharma
- Jocelyn M. Jiménez Cruz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polymorphic forms of kinase inhibitor compound, pharmaceutical comp...
- Patent number 12,209,080
- Issue date Jan 28, 2025
- EQUINOX SCIENCES, LLC
- Congxin Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glucagon receptor antagonists
- Patent number 12,208,071
- Issue date Jan 28, 2025
- Ligand Pharmaceuticals Incorporated
- Lin Zhi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor
- Patent number 12,209,073
- Issue date Jan 28, 2025
- KIORA PHARMACEUTICALS GMBH
- Stefan Sperl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Addition salt of S1P1 receptor agonist and crystal form thereof, an...
- Patent number 12,202,822
- Issue date Jan 21, 2025
- SuZhou Connect Biopharmaceuticals, Inc.
- Wei Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of tenofovir alafenamide
- Patent number 12,202,849
- Issue date Jan 21, 2025
- Gilead Sciences, Inc.
- Chiajen Lai
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Crystalline Forms of a Pharmaceutical Compound
- Publication number 20250059137
- Publication date Feb 20, 2025
- Azafaros B.V.
- Robert Hett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR...
- Publication number 20250059150
- Publication date Feb 20, 2025
- ARTHROSI THERAPEUTICS, INC.
- Shunqi YAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE AND AMORPHOUS FORMS OF A COMPOUND FOR THE TARGETED DEGR...
- Publication number 20250059168
- Publication date Feb 20, 2025
- Arvinas Operations, Inc.
- Katherine Victoria BOULTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION P...
- Publication number 20250059191
- Publication date Feb 20, 2025
- Meiji Seika Pharma Co., Ltd.
- Takao ABE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEOSIDE PHOSPHORAMIDATES
- Publication number 20250057867
- Publication date Feb 20, 2025
- GILEAD SCIENCES, INC.
- Bruce S. Ross
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for Manufacturing Pibrentasvir Active Drug Substance
- Publication number 20250051312
- Publication date Feb 13, 2025
- ABBVIE INC.
- Michael Hillier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYP...
- Publication number 20250051382
- Publication date Feb 13, 2025
- King Faisal University
- MAI MOSTAFA KHALAF ALI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE EPINEPHRINE MALONATE SALT
- Publication number 20250051262
- Publication date Feb 13, 2025
- Biothea Pharma, Inc.
- Jean-Pierre Sommadossi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TEBIPENEM PIVOXIL CRYSTALLINE FORMS, COMPOSITIONS INCLUDING THE SAM...
- Publication number 20250051334
- Publication date Feb 13, 2025
- SPERO THERAPEUTICS, INC.
- Akash JAIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYP...
- Publication number 20250051383
- Publication date Feb 13, 2025
- King Faisal University
- MAI MOSTAFA KHALAF ALI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF
- Publication number 20250049808
- Publication date Feb 13, 2025
- Trethera Corporation
- David LITZINGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF CFTR MODULATORS
- Publication number 20250051326
- Publication date Feb 13, 2025
- VERTEX PHARMACEUTICALS INCORPORATED
- Yi Shi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS OF AN FGFR INHIBITOR
- Publication number 20250051328
- Publication date Feb 13, 2025
- INCYTE CORPORATION
- Zhongjiang Jia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE BIS-MIPROCIN FUMARATE
- Publication number 20250051280
- Publication date Feb 13, 2025
- CAAMTECH, INC.
- Andrew R. CHADEAYNE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF APOL1 AND METHODS OF USING SAME
- Publication number 20250042878
- Publication date Feb 6, 2025
- VERTEX PHARMACEUTICALS INCORPORATED
- Jingrong CAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Injectable Suspensions
- Publication number 20250041206
- Publication date Feb 6, 2025
- ASARINA PHARMA AB
- Magnus Brisander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Blarcamesine co-crystals for the manufacture of pharmaceutical dosa...
- Publication number 20250042865
- Publication date Feb 6, 2025
- EGIS GYOGYSZERGYAR ZRT.
- Zsuzsanna SZOKOL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE SALTS OF N-ETHYL-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN...
- Publication number 20250042851
- Publication date Feb 6, 2025
- Gilgamesh Pharmaceuticals, Inc.
- Andrew Carry Kruegel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODUCTION METHOD FOR AROMATIC HYDROXYCARBOXYLIC ACID CRYSTAL
- Publication number 20250042833
- Publication date Feb 6, 2025
- KAO CORPORATION
- Sawa MIZOBATA MIYAKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL FORM OF BLARCAMESINE HYDROCHLORIDE, METHOD FOR PREPARING SA...
- Publication number 20250042866
- Publication date Feb 6, 2025
- Crystal Pharmaceutical (Suzhou) Co., Ltd.
- Yuxing ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALTS FOR MTOR COMPOUNDS
- Publication number 20250042908
- Publication date Feb 6, 2025
- Galderma Holding SA
- Craig Steven HARRIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE SUBSTITUTED PYRAZINES AS PGI2 RECEPTOR AGONISTS
- Publication number 20250034098
- Publication date Jan 30, 2025
- NIPPON SHINYAKU CO., LTD.
- Toshio FUJIWARA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF MANUFACTURING A SOLID FORM OF A BET BROMODOMAIN INHIBITOR
- Publication number 20250034142
- Publication date Jan 30, 2025
- ZENITH EPIGENETICS LTD
- FENG WEN
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
SALTS AND SOLID FORMS OF A COMPOUND THAT MODULATES IRAK4
- Publication number 20250034154
- Publication date Jan 30, 2025
- GILEAD SCIENCES, INC.
- Stephen E. AMMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-...
- Publication number 20250034157
- Publication date Jan 30, 2025
- ABBVIE INC.
- Ayman Allian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE SALTS OR CO-CRYSTALS OF 2',6-DIFLUORO-5'-[3-(1-HYDROXY-...
- Publication number 20250034155
- Publication date Jan 30, 2025
- NEUROCYCLE THERAPEUTICS, INC.
- Matthew TOCZKO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF (6S,7S)-6-FLUORO-7-(2-FLUORO-5-METHYLPHENYL)-3...
- Publication number 20250034129
- Publication date Jan 30, 2025
- MYOKARDIA, INC.
- Ying YU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYMORPHIC FORMS AND METHODS OF PRODUCING POLYMORPHIC FORMS OF A C...
- Publication number 20250034183
- Publication date Jan 30, 2025
- Viking Therapeutics, Inc.
- Geoffrey E. Barker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COCRYSTAL
- Publication number 20250026751
- Publication date Jan 23, 2025
- Takeda Pharmaceutical Company Limited
- Kentaro IWATA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COCRYSTALS OF NICOTINAMIDE RIBOSIDE SALTS, CRYSTALLINE FORMS, METHO...
- Publication number 20250026777
- Publication date Jan 23, 2025
- Beiture LLP
- Dedong Wu
- C07 - ORGANIC CHEMISTRY

Crystalline forms

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

De novo design of potent and selective interleukin mimetics

Crystal forms of thiophene derivatives

Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-...

Polymorphisms of HM30181 mesylate

Salt and crystalline form of furopyrimidine compound and pharmaceut...

Crystalline forms of an NRTTI compound

Compounds and compositions for inhibiting the activity of HIF2-alph...

Crystalline forms and methods of producing crystalline forms of a c...

Crystal form of acid addition salt of furopyrimidine compound

Crystalline polymorphs of sodium (4R,12AS)-9-{[(2,4-difluorophenyl)...

Crystalline forms

EGFR inhibitors

Solid forms of(Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylide...

Process for the preparation of 2,2′,2″-(10-((2R,3S)-1,3,4-trihydrox...

Crystalline forms of diazabicyclooctane derivative and production p...

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino e...

Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleu...

Nε-long chain acyl lysine crystal production method and composition...

Process for the preparation of trametinib acetic acid solvate

Cholinesterase inhibitor polymorph and application thereof

Crystal of pyrazolo[3,4-d]pyrimidine

Solid forms of 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{...

Solid form, crystalline form, and crystal form a of FXR agonist, an...

Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-b...

Crystalline forms of carbazole inhibitors of RhoGTPase for the trea...

Polymorphic forms of kinase inhibitor compound, pharmaceutical comp...

Glucagon receptor antagonists

Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor

Addition salt of S1P1 receptor agonist and crystal form thereof, an...

Crystalline forms of tenofovir alafenamide

Patents Applicationslast 30 patents

Crystalline Forms of a Pharmaceutical Compound

CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR...

CRYSTALLINE AND AMORPHOUS FORMS OF A COMPOUND FOR THE TARGETED DEGR...

CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION P...

NUCLEOSIDE PHOSPHORAMIDATES

Process for Manufacturing Pibrentasvir Active Drug Substance

NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYP...

CRYSTALLINE EPINEPHRINE MALONATE SALT

TEBIPENEM PIVOXIL CRYSTALLINE FORMS, COMPOSITIONS INCLUDING THE SAM...

NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYP...

CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF

CRYSTALLINE FORMS OF CFTR MODULATORS

SALTS OF AN FGFR INHIBITOR

CRYSTALLINE BIS-MIPROCIN FUMARATE

INHIBITORS OF APOL1 AND METHODS OF USING SAME

Injectable Suspensions

Blarcamesine co-crystals for the manufacture of pharmaceutical dosa...

CRYSTALLINE SALTS OF N-ETHYL-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN...

PRODUCTION METHOD FOR AROMATIC HYDROXYCARBOXYLIC ACID CRYSTAL

CRYSTAL FORM OF BLARCAMESINE HYDROCHLORIDE, METHOD FOR PREPARING SA...

SALTS FOR MTOR COMPOUNDS

CRYSTALLINE SUBSTITUTED PYRAZINES AS PGI2 RECEPTOR AGONISTS

METHOD OF MANUFACTURING A SOLID FORM OF A BET BROMODOMAIN INHIBITOR

SALTS AND SOLID FORMS OF A COMPOUND THAT MODULATES IRAK4

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-...

CRYSTALLINE SALTS OR CO-CRYSTALS OF 2',6-DIFLUORO-5'-[3-(1-HYDROXY-...

CRYSTALLINE FORMS OF (6S,7S)-6-FLUORO-7-(2-FLUORO-5-METHYLPHENYL)-3...

POLYMORPHIC FORMS AND METHODS OF PRODUCING POLYMORPHIC FORMS OF A C...

COCRYSTAL

COCRYSTALS OF NICOTINAMIDE RIBOSIDE SALTS, CRYSTALLINE FORMS, METHO...